Clinical Trial Update: AMT-116 in Patients with Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

This is a Phase 1/2 clinical trial evaluating AMT-116 in patients with advanced solid tumors, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• AMT-116

Snippet

Sponsor: Multitude Therapeutics Inc. | Conditions: Advanced Solid Tumors | Phase 1, Phase 2 | Status: RECRUITING